Nikulski Financial, Inc. Gilead Sciences, Inc. Transaction History

Nikulski Financial, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 12, 2019	SELL	$62.53 - $70.05 $233,111 - $261,146	-3,728 Closed	0 $0
Q4 2018 Jan 28, 2019	SELL	$60.54 - $79.0 $18,162 - $23,700	-300 Reduced 7.45%	3,728 $233,000
Q3 2018 Nov 02, 2018	SELL	$71.28 - $78.92 $40,986 - $45,379	-575 Reduced 12.49%	4,028 $275,000
Q2 2018 Aug 10, 2018	SELL	$64.88 - $75.68 $28,676 - $33,450	-442 Reduced 8.76%	4,603 $326,000
Q1 2018 May 11, 2018	SELL	$72.84 - $88.8 $43,704 - $53,280	-600 Reduced 10.63%	5,045 $380,000
Q4 2017 Feb 09, 2018	BUY	$71.15 - $83.52 $401,641 - $471,470	5,645	5,645 $404,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Nikulski Financial, Inc., based on Form 13F filings with the SEC.

Stay updated on Nikulski Financial, Inc. with notifications on news.